Search Medical Condition
Please enter condition
Please choose location

Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (175) clinical trials

Catheter ablation has been used for over a decade to treat AF patients to achieve PVI. Significant catheter design improvements (e.g., irrigated encircling catheters) focus upon improving physicians’ abilities to achieve finite entrance block following PVI. The primary intent of this study is to generate clear and sufficient safety and ...

Phase N/A

Atrial fibrillation affects approximately 2 million Americans according to the American Heart Association. This patient population comprises a substantial portion of patients seen at Baptist Health Lexington. Means of treatment includes pharmacological therapy for controlling both the rate and rhythm. In many cases, also anticoagulants are also necessary to prevent ...

Phase N/A

A research study is comparing the effectiveness of Apixaban against Vitamin K and Aspirin.

Phase N/A

This study is evaluating 2 different treatment options for persistent atrial fibrillation. In this multi-center, pivotal clinical study, patients are randomized (2:1) to either a convergent procedure that includes both epicardial and endocardial atrial ablation versus standalone endocardial catheter ablation. The study will enroll and randomize one hundred and fifty ...

Phase N/A

This study is a prospective, randomized, multi-center, global investigation to determine the safety and effectiveness of the WATCHMAN Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anticoagulation therapy to reduce the risk of stroke.

Phase N/A

To determine if the use of apixaban in patients with SCAF will reduce the incidence of stroke and systemic embolism compared to aspirin.

Phase N/A

The primary objective is to show the benefit of SmartDelay™ in patients with a prolonged RV-LV interval.

Phase N/A

People with non-valvular atrial fibrillation are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.

Phase N/A

Atrial Fibrillation and the Risk for Neurological Complications

B8: Atrial fibrillation and the risk of neurological complications Twenty-five thousand acute strokes are caused by atrial fibrillation every year. But even more frequent than symptomatic strokes are silent infarctions of the brain. Silent strokes remain undetected in most cases, but cumulate over time and progressively impair cognition. The impact ...

Phase